4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-034400
Director acquired 8,229 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
TARNOW MICHAEL M · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-18 | Exercise or conversion : show line 1 in the form | +2,057 | $3.87 | $7,961 | 71,770 | D |
| 2021-05-18 | Exercise or conversion : show line 2 in the form | +1,028 | $3.67 | $3,773 | 72,798 | D |
| 2021-05-18 | Exercise or conversion : show line 3 in the form | +5,144 | $3.67 | $18,878 | 77,942 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-18 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −2,057 | 0 | D |
| 2021-05-18 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −1,028 | 0 | D |
| 2021-05-18 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −5,144 | 0 | D |
Loading xslF345X03/doc4.xml…